No full text
Article (Scientific journals)
New generation antiepileptics for facial pain and headache
DELVAUX, Valérie; Schoenen, Jean
2001In Acta Neurologica Belgica, 101 (1), p. 42-46
Peer Reviewed verified by ORBi
 

Files


Full Text
No document available.

Send to



Details



Keywords :
antiepileptics; headache
Abstract :
[en] The prophylactic management of recurrent head and facial pains may be challenging because of lack of efficacy and/or bothersome adverse effects of available drug therapies. New generation antiepileptic drugs offer new perspectives in difficult cases. We will review the available published data and present our experience with lamotrigine in various head and facial pains such as migraine, cluster headache, neuropathic trigeminal pain, atypical facial pain, and chronic tension-type headache. Twenty-five patients were enrolled and followed for 18 months. The dose was gradually increased in steps of 25 mg up to the effective dose (mean 250 mg/d). Lamotrigine was most effective in trigeminal neuralgia and dysesthesia, but was of little utility in the other head or facial pains.
Disciplines :
Neurology
Neurosciences & behavior
Author, co-author :
DELVAUX, Valérie ;  Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman
Schoenen, Jean  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie
Language :
English
Title :
New generation antiepileptics for facial pain and headache
Publication date :
March 2001
Journal title :
Acta Neurologica Belgica
ISSN :
0300-9009
eISSN :
2240-2993
Publisher :
Acta Medica Belgica, Bruxelles, Belgium
Volume :
101
Issue :
1
Pages :
42-46
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 28 September 2009

Statistics


Number of views
60 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
17
Scopus citations®
without self-citations
16

Bibliography


Similar publications



Contact ORBi